Sensorium Therapeutics Announces Appointment of Veteran Biotech Executive Alexandra Glucksmann, Ph.D., as CEO as the Company Progresses Toward the Clinic
Glucksmann succeeds current Sensorium CEO and Co-Founder Dick Simon, who will transition to an advisory role and continue to serve on the Board of Directors
The company announces a $3 million National Institutes of Health/National Institute on Aging gra... Biopharmaceuticals, Personnel Sensorium Therapeutics, anxiety, depression (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 4, 2023 Category: Pharmaceuticals Source Type: news
Potrero Medical Announces Restructuring and Continued Operations
HAYWARD, Calif., Dec. 1, 2023 -- (Healthcare Sales & Marketing Network) -- Potrero Medical, Inc. ("Potrero" or the "Company") announced today that it has begun a voluntary restructuring of its finances by filing a pre-negotiated petiti... Devices Potrero Medical, precision fluid management (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 1, 2023 Category: Pharmaceuticals Source Type: news
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
SiteRite 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success
FRANKLIN LAKES, N.J., Nov. 30, 2023 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (... Devices, Product Launch BD , SiteRite 9, Ultrasound System, PICC (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 30, 2023 Category: Pharmaceuticals Source Type: news
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development
Led by Clarke Capital, the new funding round will accelerate the company's drug discovery pipeline
AMERICAN FORK, Utah, Nov. 29, 2023 -- (Healthcare Sales & Marketing Network) -- Biolexis Therapeutics, Inc., a clinical stage AI-driven drug discovery co... Biopharmaceuticals, Venture Capital Biolexis Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 29, 2023 Category: Pharmaceuticals Source Type: news
Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity(TM) Acute Infection and Sepsis Test System
Regulatory Milestone Designed to Expedite Path to FDA Clearance and CMS Coverage
SUNNYVALE, Calif., Nov. 28, 2023 -- (Healthcare Sales & Marketing Network) -- Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that the US Fo... Diagnostics, FDA Inflammatix, TriVerity Test System, Myrna Instrument, Sepsis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 28, 2023 Category: Pharmaceuticals Source Type: news
RTI Surgical Inc. Receives FDA IDE Approval for the Clinical Investigation of Cortiva(R) Allograft Dermis in Breast Reconstruction
ALACHUA, Fla., Nov. 27, 2023 -- (Healthcare Sales & Marketing Network) -- RTI Surgical, a leading global medical device organization, announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval fo... Devices, Surgery RTI Surgical, Cortiva, Allograft Dermis, breast reconstruction (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 27, 2023 Category: Pharmaceuticals Source Type: news
Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune(R) Oral Solution (cyclosporine oral solution, USP), 100 mg/mL due to Crystallization
EAST HANOVER, N.J., Nov. 24, 2023 -- (Healthcare Sales & Marketing Network) -- Novartis is conducting a voluntary nationwide recall at the consumer level of two lots of its Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL in the ... Biopharmaceuticals, Product Recall Novartis, Sandimmune, cyclosporine, organ transplant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 24, 2023 Category: Pharmaceuticals Source Type: news
Vaccine Partner Valneva receives FDA approval for the World's first chikungunya vaccine using Albumedix' Recombumin(R)
Albumedix Ltd ('Albumedix'), now part of the life science group Sartorius, announces that Recombumin® is critical to the manufacture of the first FDA- licensed chikungunya vaccine.
Valneva's lyophilized chikungunya vaccine IXCHIQ® is the first i... Biopharmaceuticals, FDA Albumedix, Sartorius, Valneva, Recombumin, chikungunya, vaccine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 22, 2023 Category: Pharmaceuticals Source Type: news
BD Names Dr. Ronald Silverman as Chief Medical Officer
FRANKLIN LAKES, N.J., Nov. 21, 2023 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Ronald (Ron) Silverman, MD, FACS, has been named executive v... Devices, Diagnostics, Personnel BD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 21, 2023 Category: Pharmaceuticals Source Type: news
FDA Grants Orphan Drug Designation to NeoImmuneTech's NT-I7 for the Treatment of Acute Radiation Syndrome
The FDA's Orphan Drug Designation is aimed at advancing treatments for rare diseases, including Acute Radiation Syndrome (ARS), which currently has limited treatment options
NeoImmuneTech's NT-I7 has shown potential in nonclinical studies to address the... Biopharmaceuticals, FDA NeoImmuneTech, efineptakin alfa, Acute Radiation Syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2023 Category: Pharmaceuticals Source Type: news
Vejle Hospital becomes first center in the world to use RayStation for an online adaptive treatment with augmented CBCT
STOCKHOLM, Nov. 20, 2023 -- (Healthcare Sales & Marketing Network) -- RaySearch Laboratories AB (publ) announces that University Hospital of Southern Denmark in Vejle, Denmark has developed a new and groundbreaking workflow for adapting a patient's treatm... Devices, Oncology RaySearch Laboratories, RayStation, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 20, 2023 Category: Pharmaceuticals Source Type: news
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
New organizational structure for executive leadership team designed to facilitate a leaner and more focused approach to annual execution of business plans
John Trizzino appointed to new Chief Operating Officer role
Mark Casey to join as Chief Legal O... Biopharmaceuticals, Personnel Novavax, vaccines (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 17, 2023 Category: Pharmaceuticals Source Type: news
Ad Astra Diagnostics receives 510(k) clearance of QScout(TM) hematology analyzer, the first to report measures of infection and severity at point-of-care
QScout RLD is the first test to report at point-of-care infection-fighting immature granulocytes (IGs), an early marker of sepsis, and neutrophil-to-lymphocyte ratio (NLR), a prognostic marker for several diseases including COVID-19
MORRISVILLE, N.C., ... Diagnostics, FDA Ad Astra Diagnostics, QScout (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 16, 2023 Category: Pharmaceuticals Source Type: news
Koya Medical Raises New Capital with OrbiMed to Support Growth
OAKLAND, Calif. and NEW YORK, Nov. 15, 2023 -- (Healthcare Sales & Marketing Network) -- OrbiMed, a leading healthcare investment firm and Koya Medical, a healthcare company with a mission to transform venous and lymphatic treatments through novel, people... Devices, Venture Capital Koya Medical, lymphedema, Dayspring (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 15, 2023 Category: Pharmaceuticals Source Type: news
FDA Clears Sirius Pintuition(R) for Long-term and Soft Tissue Implantation
Expanded indications further strengthen Sirius' growing Surgical Marker Navigation platform
EINDHOVEN, Netherlands , Nov. 14, 2023 -- (Healthcare Sales & Marketing Network) -- In a ground-breaking development, Sirius Medical, the leader in Surgical Mar... Devices, Oncology, Surgery, FDA Sirius Medical, Pintuition, tumor marker, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 14, 2023 Category: Pharmaceuticals Source Type: news
